echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > British Genomics and Illumina work together on genome-wide sequencing

    British Genomics and Illumina work together on genome-wide sequencing

    • Last Update: 2021-02-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    british genomics and Illumina have announced a new agreement that will allow them to deliver up to 300,000 whole genome equivalents over the next five years, with the option of increasing to 500,000.
    The partnership was established in December 2018 on the basis of the success of the 100,000 Genome Project, which established agreements to solicit the consent of patients with rare genetic diseases and cancers, tissue sample requirements, standardized DNA sequencing, data analysis and reporting.
    As part of the collaboration, samples from NHS patients with rare diseases and cancer types from England will be eligible for genome-wide sequencing to support diagnosis, inform and improve treatment pathways and ultimately improve outcomes, with the expectation that the number of eligible people with clinical adaptations will expand over time.
    Samples will be made available through nhs genomic medicine services and a network of seven genomic laboratory centres in England, which will be established in 2018.
    The project aims to achieve Health Minister Matt Hancock's ambition to analyse up to five million genomes, including genome-wide sequencing, by 2024 "to enable the UK to maintain its position as a global leader in genomics".
    Health Secretary Nicola Blackwood explained: "Genomic medicine has great potential to improve the diagnosis and treatment of some of our deadliest diseases, helping patients live longer and healthier lives.she continued: "Our 100,000 genome programmes have led to changes in the lives of many patients, and this agreement between Genomics UK and Illumina is another transformative step towards the NHS becoming truly predictive, preventive and personalized. The
    will be sequenced using NovaSeq 6000, BaseSpace Sequence Hub and Illumina analysis tools.
    Last October, research and innovation uk announced a new 200 million pound project to sequence the genetic code of half a million people to better understand, diagnose, treat and prevent life-changing diseases, including cancer and dementia. (cyy123.com)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.